Allogenic MSC infusion in kidney transplantation recipients promotes within 4 hours distinct B cell and T cell phenotypes
Exploring these CD11b<sup>+</sup>CD11c<sup>+</sup>CD38<sup>+</sup>CD39<sup>+</sup>Ki-67<sup>+</sup> B cells and T cells in the context of MSC infusion after kidney transplantation may be a promising avenue to better understand the immunological effects of MSC therapy.
Authors
- Sebastiaan Heidt (ORCID: https://orcid.org/0000-0002-6700-188X)
- Sanne H. Hendriks (ORCID: https://orcid.org/0000-0002-0974-3666)
- Marlies E. J. Reinders (ORCID: https://orcid.org/0000-0001-9543-567X)
- Frits Koning (ORCID: https://orcid.org/0000-0002-4007-5715)
- Cees van Kooten (ORCID: https://orcid.org/0000-0002-6257-0899)
Institutions
- Leiden University Medical Center (NL)
- Erasmus MC (NL)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-10-09
- DOI
- https://doi.org/10.3389/fimmu.2024.1455300
- Citations
- 1
- Primary Topic
- Mesenchymal stem cell research
- Type
- article
- Field-Weighted Citation Impact
- 0.44
Funders
- ZonMw